F-STAR THERAPEUTICS INC's ticker is FSTX and the CUSIP is 30315R107. A total of 1 filers reported holding F-STAR THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $858,888 | +146.8% | 135,900 | +100.0% | 0.00% | – |
| Q3 2022 | $348,000 | +4.5% | 67,950 | +27.8% | 0.00% | – |
| Q2 2022 | $333,000 | +76.2% | 53,150 | 0.0% | 0.00% | – |
| Q1 2022 | $189,000 | -18.2% | 53,150 | +15.6% | 0.00% | – |
| Q4 2021 | $231,000 | -31.5% | 45,970 | 0.0% | 0.00% | – |
| Q3 2021 | $337,000 | +56.7% | 45,970 | +83.4% | 0.00% | – |
| Q2 2021 | $215,000 | – | 25,070 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Advisors, Inc. | 574,996 | $2,944,000 | 1.06% |
| AlphaCentric Advisors LLC | 165,000 | $845,000 | 0.87% |
| DAFNA Capital Management LLC | 576,881 | $2,954,000 | 0.80% |
| Knott David M Jr | 235,945 | $1,208,000 | 0.51% |
| Atlas Venture Life Science Advisors, LLC | 599,524 | $3,070,000 | 0.34% |
| S. MUOIO & CO. LLC | 40,000 | $205,000 | 0.27% |
| Murchinson Ltd. | 162,624 | $833,000 | 0.24% |
| Connolly Sarah T. | 53,001 | $271,000 | 0.20% |
| BCK CAPITAL MANAGEMENT LP | 52,000 | $266,000 | 0.19% |
| Diametric Capital, LP | 44,449 | $228,000 | 0.12% |